Clinical Trial Update: A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid Recurrence [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and efficacy of various doses of STP705 for reducing keloid recurrence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloid

Drugs mentioned

• STP705

Snippet

Sponsor: Sirnaomics | Conditions: Keloid | Phase 2 | Status: COMPLETED